Dr. Leslie Discusses 2017 ASH Annual Updates

Lori A. Leslie, M.D., lymphoma attending, John Theurer Cancer Center, discusses trial updates for patients with follicular lymphoma in the maintenance setting, which were presented at the 2017 ASH Annual Meeting. The 10-year follow up of PRIMA, the randomized study looking at two years of maintenance rituximab (Rituxan).

Read full article on